Lappaconitine Derivative Hydrolysis for Osteogenesis Promotion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for bone-related diseases such as osteoporosis and fractures lack effective osteogenesis-promoting compounds, particularly derived from natural alkaloids like lappaconitine, which can enhance bone healing and density.
Innovation Solution
A novel lappaconitine derivative, represented by Formula 1, is synthesized through a process involving oxidation and reaction with organic solvents in the presence of bases, resulting in a compound that promotes osteogenesis by increasing expression of osteogenic markers and inducing stem cell differentiation into osteoblasts.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If lappaconitine is hydrolyzed to create a novel derivative, then osteogenesis-promoting activity is achieved, but the complexity of compound structure increases
Solution Approach 1:
The patent applies parameter changes by hydrolyzing lappaconitine to modify its chemical structure, specifically converting the ester group to a carboxylic acid group. This structural parameter change results in a novel derivative with enhanced osteogenesis-promoting activity while maintaining the core diterpenoid alkaloid framework.
2Object-affected harmful factors
If heat treatment is applied to reduce toxicity of aconitine, then toxic compounds are converted to less toxic forms, but the therapeutic efficacy may be reduced
Solution Approach 1:
The patent extracts the beneficial osteogenesis-promoting property from the lappaconitine structure through selective hydrolysis, isolating the active component (carboxylic acid derivative) while removing or modifying the toxic portions of the molecule. This extraction approach maintains therapeutic efficacy while reducing toxicity.
Solution Approach 2:
The patent applies parameter changes by modifying the chemical structure of lappaconitine through hydrolysis, changing the ester group to a carboxylic acid group. This structural modification alters the pharmacological properties, reducing toxicity while preserving or enhancing the desired osteogenesis-promoting therapeutic effect.
3Ease of manufacture
If existing treatments are used for bone-related diseases, then current standard care is provided, but effective osteogenesis-promoting activity is lacking
Solution Approach 1:
The patent converts the potentially harmful toxic alkaloid structure into a beneficial therapeutic agent by selective hydrolysis. The toxic lappaconitine is transformed into a less toxic derivative that specifically promotes osteogenesis, turning a harmful substance into a beneficial treatment for bone diseases.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The lappaconitine derivative effectively increases bone mineral density and promotes osteogenesis, offering potential therapeutic benefits for bone-related diseases and conditions such as osteoporosis and fractures, rheumatoid arthritis, osteoporosis, osteoporosis, osteopenia, osteomalacia, osteoarthritis, bone atrophy, bone defects, osteolysis, and osteonecrosis.
Implementation Method 1
inducing stem cell differentiation into osteoblasts
Implementation Method 2
hydrolyzing lappaconitine while conducting research on new pharmacological activities of lappaconitine
Data Source
AI summary
The present invention pertains to a novel lappaconitine derivative, a method for producing same, and a pharmaceutical use thereof using osteogenesis-promoting activity. The lappaconitine derivative induces the differentiation of stem cells into osteoblasts, increases bone mineral density when administered to animal models of osteoporosis, and induces bone formation in animal models of bone fracture, and thus can be advantageously used for preventing, ameliorating, or treating bone-related diseases such as osteoporosis, as well as treating non-disease fractures caused by physical trauma.